Healthy women who have had a prior cesarean delivery can safely delivery vaginally. That is the conclusion of a 14-year retrospective study at the John H. Stroger Jr. Hospital of Cook County, IL.
Healthy women who have had a prior cesarean delivery can safely delivery vaginally. That is the conclusion of a 14-year retrospective study at the John H. Stroger Jr. Hospital of Cook County, IL.
Sylvia Moscoso, MD, and Tuan Nguyen, MD, reviewed records for women who had delivered by C/S between January 1990 and December 2003 at Cook County Hospital. The study group had a subsequent trial of labor with no intervening births, no medical or obstetrical complications during pregnancy, and delivered fetuses weighing more than 4,000 g. Just 62 women met study criteria, according to Dr. Moscoso. Twenty-two women (35.5%) chose to deliver vaginally and 40 women (64.5%) opted to deliver by repeat cesarean.
There were no statistically significant differences between the two groups in birth weights or Apgar scores at 1 and 5 minutes postpartum and none of the women had uterine rupture. There were two cases of shoulder dystocia in the vaginal delivery group, but neither infant had brachial plexus injuries. There were no significant maternal or neonatal morbidities in either birth group.
Based on the Chicago experience, healthy women with a previous C/S and no other deliveries who expect to deliver a fetus weighing over 4,000 g can be counseled that vaginal delivery is a viable birth option.
Moscoso S, Nguyen TM. Trial of labor after cesarean delivery and fetuses more than 4,000 g: The 14-year experience at Cook County. Obstet Gynecol. 2005;105(4 suppl):41S.
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
No link found between prenatal cannabis use and childhood developmental delay
November 5th 2024In a recent study, offspring of women with cannabis use in early pregnancy confirmed by self-report or toxicology test were not at an increased risk of childhood early developmental delay up to the age of 5.5 years.
Read More
Prenatal cannabis use not linked to offspring ASD development
November 1st 2024In a recent study, adjustments for maternal characteristics mediated the association between maternal prenatal cannabis use and offspring autism spectrum disorder, indicating no statistically significant increase in risk.
Read More
Importance of reproductive health services for adolescents during the COVID-19 pandemic
October 30th 2024In a recent study, high rates of reproductive health service use were reported among adolescent mothers, indicating the benefits of this model for providing care when other options are unavailable.
Read More